Cargando…

Development and application of therapeutic antibodies against COVID-19

The pandemic of Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2) continues to be a global health crisis. Fundamental studies at genome, transcriptome, proteome, and interactome levels have revealed many viral and host targets for therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Lin, Abagna, Hamza B., Jiang, Qianhu, Liu, Siqi, Huang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071770/ https://www.ncbi.nlm.nih.gov/pubmed/33907512 http://dx.doi.org/10.7150/ijbs.59149

Ejemplares similares

SSH2.0: A Better Tool for Predicting the Hydrophobic Interaction Risk of Monoclonal Antibody
por: Zhou, Yuwei, et al.
Publicado: (2022)

Development and application of ribonucleic acid therapy strategies against COVID-19
por: Ning, Lin, et al.
Publicado: (2022)

Diversity and immune responses against Plasmodium falciparum gametocytes in non-febrile school children living in Southern Ghana
por: Amoah, Linda E., et al.
Publicado: (2019)

Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII–V in Ghanaian children living in two communities with varying malaria transmission patterns
por: Abagna, Hamza B., et al.
Publicado: (2018)

Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
por: Chen, Junsen, et al.
Publicado: (2021)

Development of Antibody Therapeutics against Flaviviruses
por: Sun, Haiyan, et al.
Publicado: (2017)

An update to monoclonal antibody as therapeutic option against COVID-19
por: Deb, Paroma, et al.
Publicado: (2021)

Convalescent plasma to deliver therapeutic antibodies against COVID-19
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

Development and applications of a monoclonal antibody against caprine interferon-gamma
por: Ma, Wen-Tao, et al.
Publicado: (2019)

Fc-engineered antibody therapeutics with improved efficacy against COVID-19
por: Yamin, Rachel, et al.
Publicado: (2021)

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020)

Understanding the Cognitive Immersion of Hospitality Architecture in Culture and Nature: Cultural Psychology and Neuroscience Views
por: Xie, Haihui, et al.
Publicado: (2022)

A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19
por: Asdaq, Syed Mohammed Basheeruddin, et al.
Publicado: (2021)

Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
por: Sun, Jin, et al.
Publicado: (2023)

Persistent Plasmodium falciparum infections enhance transmission-reducing immunity development
por: Ayanful-Torgby, Ruth, et al.
Publicado: (2021)

Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2
por: Li, Pi-Chun, et al.
Publicado: (2012)

COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19
por: Yang, Lifei, et al.
Publicado: (2020)

Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID‐19
por: Huang, Jiansheng, et al.
Publicado: (2020)

Systems Biology Approaches for Therapeutics Development Against COVID-19
por: Jaiswal, Shweta, et al.
Publicado: (2020)

Neutralizing Antibody Therapeutics for COVID-19
por: Hurt, Aeron C., et al.
Publicado: (2021)

Development of Polyclonal Antibody against Clenbuterol for Immunoassay Application
por: Talib, Nurul Ain A., et al.
Publicado: (2018)

AB-Amy: machine learning aided amyloidogenic risk prediction of therapeutic antibody light chains
por: Zhou, Yuwei, et al.
Publicado: (2023)

Therapeutic Applications of Monoclonal Antibodies
por: Berger, Mitchell, et al.
Publicado: (2002)

Erica Ollmann Saphire: How the Study of HIV and Other Viruses Informed the Rapid Development of Vaccines and Therapeutic Antibodies Against COVID-19
por: Greenspan, Neil S.
Publicado: (2022)

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
por: Oliphant, Theodore, et al.
Publicado: (2005)

Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
por: Kang, Seung Hyun, et al.
Publicado: (2021)

Prion Protein-Specific Antibodies-Development, Modes of Action and Therapeutics Application
por: Rovis, Tihana Lenac, et al.
Publicado: (2014)

Therapeutic strategies against COVID-19
por: Esposito, Susanna, et al.
Publicado: (2020)

Single-Domain Antibodies As Therapeutics against Human Viral Diseases
por: Wu, Yanling, et al.
Publicado: (2017)

Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?
por: Li, Jianhua, et al.
Publicado: (2020)

DIPG-56. Development and application of a novel antibody against CD99 as a therapeutic strategy in Diffuse Midline Glioma
por: Venkataraman, Sujatha, et al.
Publicado: (2022)

Dosing Considerations for Antibodies Against COVID-19
por: Tegenge, Million A., et al.
Publicado: (2020)

Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022)

Broadly neutralizing antibodies against COVID-19
por: Zhou, Daming, et al.
Publicado: (2023)

Development of applicable thiol-linked antibody–drug conjugates with improved stability and therapeutic index
por: Wang, Yanming, et al.
Publicado: (2022)

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
por: Zhao, Shaojuan, et al.
Publicado: (2021)

The pharmacology and therapeutic applications of monoclonal antibodies
por: Castelli, María Sofía, et al.
Publicado: (2019)

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
por: Kumari, Monika, et al.
Publicado: (2022)

Development of therapeutic antibodies for the treatment of diseases
por: Lu, Ruei-Min, et al.
Publicado: (2020)

Therapeutic Antibodies against Intracellular Tumor Antigens
por: Trenevska, Iva, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2p8vcqjgvavlrf4himim5o8tp5